| Reporter | TradeFlow | ProductCode | Product Description | Year | Partner | Trade Value 1000USD | Quantity | Quantity Unit |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | World | 1,397.10 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Other Asia, nes | 432.55 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | New Caledonia | 208.95 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Lebanon | 135.19 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | United Arab Emirates | 128.55 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | New Zealand | 125.41 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Vietnam | 66.37 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Colombia | 42.78 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Oman | 35.09 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Fiji | 31.59 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Myanmar | 25.38 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Kuwait | 23.44 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Thailand | 21.60 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Kiribati | 18.49 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Italy | 14.81 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | United Kingdom | 14.64 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Papua New Guinea | 12.40 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Singapore | 12.29 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Philippines | 9.16 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Egypt, Arab Rep. | 8.70 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Nauru | 7.00 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Nepal | 4.40 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Bahrain | 4.01 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Solomon Islands | 3.91 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Qatar | 3.48 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Indonesia | 2.13 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | China | 1.94 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Sri Lanka | 1.56 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Tonga | 1.28 | | |
